Current methods of antibody detection, such as conventional serological assays, are limited in terms of the amount of ...

People go to great lengths to maintain youthful-looking skin with masks, creams and serums. Now, researchers have discovered ...

The strong immune response was confirmed in CHIKV-naïve children with a 96.5% seroresponse rate (full dose) at Day 180. VLA1553 was well tolerated in children aged one to eleven years regardless of ...

New research suggests that an antibody-drug conjugate may offer practice-changing, patient-friendly treatment of blastic ...

Leuven, Belgium, June 5, 2025 – AstriVax Therapeutics NV, a clinical stage immunotherapy company developing novel treatments for chronic infections based on its proprietary Launch-iT technology, ...

This study presents compelling evidence that the denitrosylase SCoR2 regulates cardioprotective metabolic reprogramming in the heart following ischemia/reperfusion injury. The findings are supported ...

The US Department of Health and Human Services will not extend a grant funding the Center for HIV/AIDS Vaccine Development, ...

The results feed into an effort to identify to monoclonal antibody combinations that would prevent and possibly treat HIV ...

Enhertu, Datroway and other antibody-drug conjugates developed by Daiichi Sankyo have made the company a leader in a ...

Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.

In this week’s edition of InnovationRx, we look at the impact of Trump’s proposed budget cuts on biomedical research and ...

Rina-S led to a 50% response rate, including two complete responses, in heavily pretreated advanced endometrial cancer, ...